A large-scale genetic correlation scan between rheumatoid arthritis and human plasma protein
10.1302/2046-3758.112.bjr-2021-0270.r1 · doi-reference
Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study
10.1186/s12967-023-04474-z · doi-reference
EHBP1 SNPs, Their Haplotypes, and Gene-Environment Interactive Effects on Serum Lipid Levels
10.1021/acsomega.9b03522 · doi-reference
Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I
10.1016/j.ymgme.2014.09.012 · doi-reference
Linking epileptic phenotypes and neural extracellular matrix remodeling signatures in mouse models of epilepsy
10.1016/j.nbd.2023.106324 · doi-reference
Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders
10.1093/schbul/sbad100 · doi-reference
Candidate gene analysis of the human natural killer-1 carbohydrate pathway and perineuronal nets in schizophrenia: B3GAT2 is associated with disease risk and cortical surface area
10.1016/j.biopsych.2010.07.035 · doi-reference
Hapln4/Bral2 is a selective regulator for formation and transmission of GABAergic synapses between Purkinje and deep cerebellar nuclei neurons
10.1111/jnc.14571 · doi-reference
ERK1/2 activation induced by inflammatory cytokines compromises effective host tissue integration of engineered cartilage
10.1089/ten.tea.2008.0663 · doi-reference
Expression of CILP-2 and DDR2 and ultrastructural changes in the articular cartilage of patients with knee osteoarthritis undergoing total knee arthroplasty: a pilot morphological study
10.1007/s00795-022-00339-4 · doi-reference
Association between changes in molecular biomarkers of cartilage matrix turnover and changes in knee articular cartilage: a longitudinal pilot study
10.1186/s40634-019-0179-3 · doi-reference
Differences in biomarkers of cartilage matrix turnover and their changes over 2 years in adolescent and adult volleyball athletes
10.1186/s40634-017-0081-9 · doi-reference
Cartilage intermediate layer protein 2 (CILP-2) is expressed in articular and meniscal cartilage and down-regulated in experimental osteoarthritis
10.1074/jbc.m111.248039 · doi-reference
Functional genomics atlas of synovial fibroblasts defining rheumatoid arthritis heritability
10.1186/s13059-021-02460-6 · doi-reference
Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients
10.1136/annrheumdis-2011-201225 · doi-reference
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
10.1038/ng.233 · doi-reference
A20 controls RANK-dependent osteoclast formation and bone physiology
10.15252/embr.202255233 · doi-reference
A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis
10.1038/ng.874 · doi-reference
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology
10.1016/j.it.2009.05.007 · doi-reference
CD4 and B lymphocyte expression quantitative traits at rheumatoid arthritis risk loci in patients with untreated early arthritis: implications for causal gene identification
10.1002/art.40393 · doi-reference
Non-HLA genes modulate the risk of rheumatoid arthritis associated with HLA-DRB1 in a susceptible North American Native population
10.1038/gene.2011.30 · doi-reference
The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases
10.1136/ard.2007.077826 · doi-reference
Genetics of rheumatoid arthritis: underlying evidence of ethnic differences
10.1016/j.jaut.2009.02.020 · doi-reference
Ethnogenetic heterogeneity of rheumatoid arthritis-implications for pathogenesis
10.1038/nrrheum.2010.23 · doi-reference
Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis
10.1136/ard.2005.048454 · doi-reference
Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association
10.1210/jc.2006-2183 · doi-reference
Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population
10.1002/art.22270 · doi-reference
FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians
10.1136/ard.2006.064949 · doi-reference
Fc receptor-like 3 -169 C/T polymorphism and RA susceptibility: a meta-analysis
10.1007/s00296-009-1082-5 · doi-reference
FCRL3 gene polymorphisms as risk factors for rheumatoid arthritis
10.1016/j.humimm.2015.12.007 · doi-reference
Regulation of TNF-α with a focus on rheumatoid arthritis
10.1038/icb.2013.15 · doi-reference
NF-κB Signaling Pathway in Rheumatoid Arthritis: Mechanisms and Therapeutic Potential
10.1007/s12035-024-04634-2 · doi-reference
The role of interleukin-17 in the pathogenesis of rheumatoid arthritis
10.1007/s11926-009-0052-y · doi-reference
E3 ubiquitin ligase gene BIRC3 modulates TNF-induced cell death pathways and promotes aberrant proliferation in rheumatoid arthritis fibroblast-like synoviocytes
10.3389/fimmu.2024.1433898 · doi-reference
Ubiquitin D promotes the progression of rheumatoid arthritis via activation of the p38 MAPK pathway
10.3892/mmr.2023.12940 · doi-reference
L. donovani XPRT: Molecular characterization and evaluation of inhibitors
10.1016/j.bbapap.2017.12.002 · doi-reference
Molecular dynamics with coupling to an external bath
10.1063/1.448118 · doi-reference
Strain fluctuations and elastic constants
10.1063/1.443248 · doi-reference
CHARMM36m: an improved force field for folded and intrinsically disordered proteins
10.1038/nmeth.4067 · doi-reference
GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation
10.1021/ct700301q · doi-reference
